multiple sclerosis

Europe revokes marketing authorization for generic versions of Biogen's MS drug
Reuters
Tue, 12/19/23 - 10:08 am
Biogen
Tecfidera
MS
multiple sclerosis
Europe
generics
Genentech's MS drug on partial hold in US after liver enzyme elevations in 2 patients
Fierce Biotech
Mon, 12/4/23 - 06:14 pm
Genentech
Roche
MS
multiple sclerosis
fenebrutinib
clinical trials
Merck KGaA, with hold still clouding prospects, guides MS drug past durability test ahead of phase 3 data
Fierce Biotech
Wed, 10/11/23 - 10:20 am
Merck KGaA
evobrutinib
MS
multiple sclerosis
clinical trials
Roche preps for filings after subcutaneous Ocrevus matches up to IV formulation in phase 3 study
Fierce Pharma
Wed, 10/11/23 - 10:07 am
Roche
Ocrevus
MS
multiple sclerosis
clinical trials
A Breakthrough in Interferon-based Therapies for Multiple Sclerosis
BioSpace
Wed, 09/27/23 - 10:08 am
Heligenics
MS
multiple sclerosis
beta interferon
genomics
FDA Approves Sandoz Biosimilar to Biogen’s MS Therapy Tysabri
BioSpace
Fri, 08/25/23 - 09:53 am
Biogen
Sandoz
FDA
biosimilars
MS
multiple sclerosis
Tysabri
Teva's trial in high-stakes kickbacks case delayed as company pursues rare pretrial appeal
Fierce Pharma
Wed, 08/16/23 - 11:11 pm
Teva Pharmaceutical
kickbacks
Copaxone
MS
multiple sclerosis
TG shares tumble following licensing deal for MS drug
BioPharma Dive
Tue, 08/1/23 - 10:24 pm
TG Therapeutics
MS
multiple sclerosis
Briumvi
Phase III trial results bring subcutaneous Ocrevus closer to its potential approval
Clinical Trials Arena
Mon, 07/31/23 - 10:09 am
Roche
Ocrevus
clinical trials
MS
multiple sclerosis
Roche eyes alternate mode of administration for Ocrevus in MS
Clinical Trials Arena
Thu, 07/13/23 - 10:21 am
Roche
Ocrevus
clinical trials
MS
multiple sclerosis
Sanofi sees midphase success in multiple sclerosis decades after safety concerns scuttled peers
Fierce Biotech
Wed, 05/31/23 - 10:54 am
Sanofi
MS
multiple sclerosis
clinical trials
frexalimab
Biogen chalks up a Tecfidera patent win in Europe after losing US protections
Fierce Pharma
Fri, 05/5/23 - 11:50 am
Biogen
Tecfidera
multiple sclerosis
Europe
J&J opens the valve on $50M MS partnership with Pipeline
Fierce Biotech
Mon, 04/17/23 - 12:40 pm
JNJ
Pipeline Therapeutics
MS
multiple sclerosis
PIPE-307
Merck KGaA's multiple sclerosis drug hit with partial FDA hold, adding to BTK-liver injury links
Fierce Biotech
Wed, 04/12/23 - 11:52 am
Merck KGaA
multiple sclerosis
MS
Btk inhibitors
liver damage
Immunic punts psoriasis, prostate cancer programs to narrow focus onto multiple sclerosis, celiac disease
Fierce Biotech
Thu, 04/6/23 - 10:01 am
Immunic
prostate cancer
psoriasis
MS
multiple sclerosis
celiac disease
Biogen gets EU court ruling in favor of blocking Tecfidera generic entry
Seeking Alpha
Thu, 03/16/23 - 09:44 am
Biogen
EMA
Europe
MS
multiple sclerosis
Tecfidera
generics
Roche sues Biogen over royalties related to multiple sclerosis drug Tysabri
Fierce Pharma
Wed, 03/1/23 - 07:08 pm
Roche
Genentech
patents
MS
multiple sclerosis
legal
Tysabri
Novartis loses $940M arbitration case against Mitsubishi Chemical over Gilenya royalties
Fierce Pharma
Mon, 02/20/23 - 12:42 pm
Novartis
Mitsubishi Chemical
multiple sclerosis
MS
Supreme Court
legal
patents
Gilenya
Novartis petitions Supreme Court in effort to 'vigorously defend' Gilenya patent
Endpoints
Tue, 01/24/23 - 06:18 pm
Novartis
Supreme Court
Gilenya
patents
generics
multiple sclerosis
MS
FDA approves drugs from Gilead, Roche, TG Therapeutics to close 2022
BioPharma Dive
Wed, 01/4/23 - 10:11 am
FDA
drug approvals
HIV
lymphoma
multiple sclerosis
Gilead Sciences
Roche
TG Therapeutics

Pages